Edition:
United States

Cronos Group Inc (MJN.V)

MJN.V on TSX Venture Exchange

2.53CAD
3:59pm EDT
Change (% chg)

$-0.08 (-3.07%)
Prev Close
$2.61
Open
$2.65
Day's High
$2.65
Day's Low
$2.53
Volume
259,423
Avg. Vol
208,028
52-wk High
$3.54
52-wk Low
$0.79

Chart for

About

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs,... (more)

Overall

Beta: --
Market Cap(Mil.): $355.35
Shares Outstanding(Mil.): 136.15
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.67 16.08
EPS (TTM): -- -- --
ROI: -- 15.12 14.60
ROE: -- 16.35 14.03

BRIEF-Cronos announces upsizing of private placement of common shares

* Cronos announces upsizing of private placement of common shares

Sep 18 2017

BRIEF-Cronos announces private placement of common shares

* Cronos Group Inc - ‍ expects to issue, by way of a non-brokered private placement, up to 4.4 million common shares at a price of $2.25 per offered share​ Source text for Eikon: Further company coverage:

Sep 14 2017

BRIEF-Cronos establishes international low cost production in Israel

* Cronos Group - ‍Entered into strategic JV With Kibbutz Gan Shmuel for production, manufacture and global distribution of medical cannabis​

Sep 06 2017

BRIEF-Cronos Group Q2 sales $643k vs $514k in Q1

* Cronos Group files Q2 2017 financial results and provides operational update

Aug 28 2017

BRIEF-Cronos Group secures $40 mln in debt for domestic capacity expansion

* Cronos Group secures $40m in debt for domestic capacity expansion

Aug 24 2017

Earnings vs. Estimates